Etienne M. Meylan

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.

Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.

Journal: EMBO molecular medicine

Published: September 10, 2025

Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control.

Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control.

Journal: Journal for immunotherapy of cancer

Published: May 21, 2025

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

Journal: Oncoimmunology

Published: December 19, 2024

Hyperthermic Intrathoracic Chemotherapy Modulates the Immune Microenvironment of Pleural Mesothelioma and Improves the Impact of Dual Immune Checkpoint Inhibition.

Hyperthermic Intrathoracic Chemotherapy Modulates the Immune Microenvironment of Pleural Mesothelioma and Improves the Impact of Dual Immune Checkpoint Inhibition.

Journal: Cancer immunology research

Published: March 11, 2024

Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth.

Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth.

Journal: EMBO molecular medicine

Published: June 28, 2023

Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model.

Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 07, 2022

Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.

Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.

Journal: Journal for immunotherapy of cancer

Published: April 04, 2022

Neutrophil phenotypes and functions in cancer: A consensus statement.

Neutrophil phenotypes and functions in cancer: A consensus statement.

Journal: The Journal of experimental medicine

Published: December 23, 2021

Neutrophil metabolism in the cancer context.

Neutrophil metabolism in the cancer context.

Journal: Seminars in immunology

Published: October 15, 2021

Neutrophils in the era of immune checkpoint blockade.

Neutrophils in the era of immune checkpoint blockade.

Journal: Journal for immunotherapy of cancer

Published: July 01, 2021

Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy.

Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy.

Journal: Oncoimmunology

Published: February 25, 2021

GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.

GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.

Journal: Cancer research

Published: August 21, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026